Recurrent/Refractory Malignant Lymphoma
1 clinical trials · Condition
◉ Watch Recurrent/Refractory Malignant Lymphoma
| Record | Firm | Date |
|---|---|---|
| A Phase I Clinical Study of JS004 in Subjects With Recurrent/Refractory Malignant Lymphoma of China (NCT04477772) | Shanghai Junshi Bioscience Co., Ltd. | 2020-07-17 |
Track Recurrent/Refractory Malignant Lymphoma automatically
Every clearance here is in the API, with alerts when new ones post.